# Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

> **NCT01376349** · PHASE3 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 464 (actual)

## Conditions studied

- Breast Cancer
- Gynecologic Cancer

## Interventions

- **DRUG:** prasterone
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01376349
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2013-08
- **Final completion:** 2017-11
- **Target enrollment:** 464 (ACTUAL)
- **Last updated:** 2019-02-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01376349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01376349, "Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01376349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*